Background: Even with optimal pharmacotherapy, symptomatic heart failure is associated
with substantial morbidity and mortality. Purpose: To determine the efficacy and safety of …

Since the first implantable cardiac pacemaker was patented in 1959 by Greatbatch and
implanted in 1960, 1 there have been rapid advancements in the technology and in the …

Background We tested the hypothesis that prophylactic cardiac-resynchronization therapy in
the form of biventricular stimulation with a pacemaker with or without a defibrillator would …

OBJECTIVES: To compare durability of tricuspid valve annuloplasty techniques, identify risk
factors for repair failure, and characterize survival, reoperation, and functional class of …

Objectives: Our objective was to evaluate the short-term safety and efficacy of cardiac
resynchronization therapy (CRT) in children. Background: Cardiac resynchronization …

Objectives: The objective of this study was to assess the usefulness of each type of strain for
left ventricular (LV) dyssynchrony assessment and its predictive value for a positive …

Aims To assess the impact of MultiPoint™ Pacing (MPP)—programmed according to the
physician's discretion—in non-responders to standard biventricular pacing after 6 months …

Patients with dilated cardiomyopathy and discoordinate wall motion due to intraventricular
conduction delay are at increased risk for exacerbated pump failure and arrhythmias and …

Background The purpose of this study was to assess the independent contribution of left
bundle branch block (LBBB) on long-term mortality in a large cohort with symptomatic heart …

Introduction Presence of scar at the implantation‐site is considered as a major factor in
determining the success of left bundle branch pacing (LBBP). We aimed at analyzing the …